Doctors are set to prescribe a weight loss jab to NHS patients struggling with obesity in a new trial.
The government will hold a two-year pilot costing £40million. The medicines watchdog NICE approved the use of semaglutide earlier this year after finding it was safe, effective and affordable.
The drug, which is marketed as Wegovy, is injected into the skin and makes people feel fuller, leading them to eat less. The jabs have been popular in the United States where they have been used by celebrities, including Twitter owner Elon Musk.